A Note About COVID-19 for Patients Enrolled in our Clinical Studies | Questions About Our Medicines? Visit medinfo.roche.com

 

Roche has established a multi-lingual global hotline (Phone: +36 146 182 58 | WhatsApp/SMS: + 36 707 177 394) and email (patientcare@roche.com) for patients and healthcare providers in or from Ukraine. We will do our best to provide everyone who is in need with the appropriate information and support.

Bladder Cancer

What is bladder cancer?

Bladder cancer is characterised by the development of abnormal cells in the lining of the bladder.2 There are three main types of bladder cancer:2

  • Urothelial carcinoma, also known as transitional cell carcinoma (TCC), which develops in the cells of the bladder lining. It is by far the most common type of bladder cancer, accounting for about 90% of all cases.
  • Squamous cell carcinoma, which begins in squamous cells of the bladder lining, and accounts for 4% of all bladder cancers.
  • Adenocarcinoma, which begins in glandular cells in the lining of the bladder, and accounts for 2% of all bladder cancers.

Learn more about bladder cancer and research at Roche.

Clinical Research Explained

Information about what clinical trials and observational studies are. Understand why you might want to take part in clinical research and why diversity in clinical research is important.

Find out now